Content area
Title
Author Correction: Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias
Author
Raundhal Mahesh 1
; Shrestha, Ghosh 1 ; Myers, Samuel A 2 ; Cuoco, Michael S 3 ; Singer Meromit 4 ; Carr, Steven A 2 ; Waikar, Sushrut S 5 ; Bonventre, Joseph V 6
; Ritz, Jerome 7 ; Stone, Richard M 7 ; Steensma, David P 7 ; Regev Aviv 8
; Glimcher, Laurie H 1
1 Dana-Farber Cancer Institute, Department of Cancer Immunology and Virology, Boston, USA (GRID:grid.65499.37) (ISNI:0000 0001 2106 9910); Harvard Medical School, Department of Immunology, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Brigham and Women’s Hospital, Department of Medicine, Boston, USA (GRID:grid.62560.37) (ISNI:0000 0004 0378 8294)
2 Broad Institute of MIT and Harvard, Cambridge, USA (GRID:grid.66859.34)
3 Broad Institute of Harvard and MIT, Klarman Cell Observatory, Cambridge, USA (GRID:grid.66859.34)
4 Harvard Medical School, Department of Immunology, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Broad Institute of MIT and Harvard, Cambridge, USA (GRID:grid.66859.34); Dana-Farber Cancer Institute, Department of Data Sciences, Boston, USA (GRID:grid.65499.37) (ISNI:0000 0001 2106 9910)
5 Brigham and Women’s Hospital, Harvard Medical School, Renal Division, Department of Medicine, Boston, USA (GRID:grid.62560.37) (ISNI:0000 0004 0378 8294); Boston University Medical Center, Renal Section, Boston, USA (GRID:grid.239424.a) (ISNI:0000 0001 2183 6745)
6 Brigham and Women’s Hospital, Harvard Medical School, Renal Division, Department of Medicine, Boston, USA (GRID:grid.62560.37) (ISNI:0000 0004 0378 8294)
7 Dana-Farber Cancer Institute, Harvard Medical School, Department of Medical Oncology, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
8 Broad Institute of Harvard and MIT, Klarman Cell Observatory, Cambridge, USA (GRID:grid.66859.34); Howard Hughes Medical Institute, Chevy Chase, USA (GRID:grid.413575.1) (ISNI:0000 0001 2167 1581); Massachusetts Institute of Technology, Koch Institute for Integrative Cancer Research, Department of Biology, Cambridge, USA (GRID:grid.116068.8) (ISNI:0000 0001 2341 2786)
; Shrestha, Ghosh 1 ; Myers, Samuel A 2 ; Cuoco, Michael S 3 ; Singer Meromit 4 ; Carr, Steven A 2 ; Waikar, Sushrut S 5 ; Bonventre, Joseph V 6
; Ritz, Jerome 7 ; Stone, Richard M 7 ; Steensma, David P 7 ; Regev Aviv 8
; Glimcher, Laurie H 1
1 Dana-Farber Cancer Institute, Department of Cancer Immunology and Virology, Boston, USA (GRID:grid.65499.37) (ISNI:0000 0001 2106 9910); Harvard Medical School, Department of Immunology, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Brigham and Women’s Hospital, Department of Medicine, Boston, USA (GRID:grid.62560.37) (ISNI:0000 0004 0378 8294)
2 Broad Institute of MIT and Harvard, Cambridge, USA (GRID:grid.66859.34)
3 Broad Institute of Harvard and MIT, Klarman Cell Observatory, Cambridge, USA (GRID:grid.66859.34)
4 Harvard Medical School, Department of Immunology, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Broad Institute of MIT and Harvard, Cambridge, USA (GRID:grid.66859.34); Dana-Farber Cancer Institute, Department of Data Sciences, Boston, USA (GRID:grid.65499.37) (ISNI:0000 0001 2106 9910)
5 Brigham and Women’s Hospital, Harvard Medical School, Renal Division, Department of Medicine, Boston, USA (GRID:grid.62560.37) (ISNI:0000 0004 0378 8294); Boston University Medical Center, Renal Section, Boston, USA (GRID:grid.239424.a) (ISNI:0000 0001 2183 6745)
6 Brigham and Women’s Hospital, Harvard Medical School, Renal Division, Department of Medicine, Boston, USA (GRID:grid.62560.37) (ISNI:0000 0004 0378 8294)
7 Dana-Farber Cancer Institute, Harvard Medical School, Department of Medical Oncology, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
8 Broad Institute of Harvard and MIT, Klarman Cell Observatory, Cambridge, USA (GRID:grid.66859.34); Howard Hughes Medical Institute, Chevy Chase, USA (GRID:grid.413575.1) (ISNI:0000 0001 2167 1581); Massachusetts Institute of Technology, Koch Institute for Integrative Cancer Research, Department of Biology, Cambridge, USA (GRID:grid.116068.8) (ISNI:0000 0001 2341 2786)
Nature Immunology; New York
Volume
22
Issue
11
First page
1465
End page
1465
Publication year
2021
Publication date
Nov 2021
Place of publication
New York
Country of publication
United States
Publication subject
ISSN
15292908
e-ISSN
15292916
Source type
Scholarly Journal
Language of publication
English
Document type
Corrections/Retraction
Publication history
Online publication date
2021-09-14
Milestone dates
2021-08-17 (Registration)
Publication history
First posting date
14 Sep 2021
ProQuest document ID
2587482286
Document URL
https://www.proquest.com/scholarly-journals/author-correction-blockade-il-22-signaling/docview/2587482286/se-2?accountid=208611
Copyright
© The Author(s), under exclusive licence to Springer Nature America, Inc. 2021.
Last updated
2024-10-09
Database
ProQuest One Academic